SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI (RZLV) is trending due to positive sentiment around its AI-driven commerce solutions and recent news of Crispin Lowery, former Microsoft Retail Head, joining as EVP of Growth. The community discusses the potential for significant growth, fueled by partnerships with tech giants and upcoming earnings on October 1st. Some traders are looking for a dip to add to their positions, while others are setting price targets based on growth expectations.

TOSHI

TOSHI is trending amid community excitement, with some speculating about potential listings on additional exchanges and anticipation surrounding possible impacts from upcoming Fed rate news. The community is actively discussing its potential for significant gains and comparing it to other meme coins, while also highlighting its presence on the Base network and partnership with Coinbase. Some users also mention buying opportunities amid recent price movement.

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.

Vyome Holdings Inc.

Vyome Holdings (HIND) is trending due to an upcoming merger vote, with the community anticipating a positive outcome and a ticker change to HIND. Bullish sentiment surrounds the potential for a low-float squeeze and long-term growth, driven by Vyome's pipeline. Some traders are discussing the potential for a post-merger run, drawing comparisons to other recently merged stocks.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as the community discusses its potential nationwide expansion and anticipation of the Fed's interest rate decision, with some highlighting the stock's short squeeze potential. Community members are debating the impact of "Pharma Bro" Martin Shkreli's short position, while others express confidence in the new CEO and long-term growth prospects in real estate. The stock's volatility and potential for significant price swings are also key talking points.

CaliberCos, Inc. operates as an asset management firm. It provides various support services including asset management & fund set-up services, as well as lending support, construction & development management, and real estate brokerage services. The company was founded by John Christopher Loeffler II and Jennifer Schrader in January 2009 and is headquartered in Scottsdale, AZ.

CaliberCos Inc - Ordinary Shares - Class A

CaliberCos Inc 

CaliberCos ($CWD) is trending due to a recent announcement of a $15.9 million preferred stock sale and ATM program activation, sparking volatility and mixed reactions. The community is debating the implications of the preferred equity's conversion price and the potential for manipulation, while some anticipate a short squeeze given the high short interest.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals (QNRX) is trending with high volume as traders discuss its "insane momentum" and potential for further gains, possibly to $20. Bullish sentiment seems to be driven by positive clinical data, specifically related to a pediatric peeling skin syndrome study, with some community members noting the stock's low float and potential for a short squeeze. However, some traders caution about potential pump-and-dump dynamics or dilution.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Shares of DJT are attracting significant attention amidst discussions about political motivations and the Epstein files, with community members debating the relevance and potential implications. The stock is also influenced by broader political narratives, with some linking its performance to the current administration's policies and potential future deals. Community sentiment appears divided along political lines, impacting trading behavior.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix ($NFLX) is trending due to an analyst upgrade from Loop Capital, citing strong engagement and a promising content slate. Community discussions revolve around whether the stock can sustain its upward momentum, with some speculating on potential catalysts like a stock split. Broader conversations also touch on Netflix's position in the streaming landscape amid potential shifts in the media sector.

Presidio Property Trust, Inc. is a self-managed real estate investment trust, which invests in a diverse multi-tenant portfolio of real estate assets. It operates through the following segments: Office and Industrial Properties, Model Home Properties, and Retail Properties. The Office and Industrial Properties segment consists of office buildings and an industrial property leased to a variety of tenants ranging from small businesses to large public companies. The Model Home Properties segment consists of model home residential properties leased to homebuilders. The Retail Properties segment includes shopping centers. The company was founded by Jack Kendrick Heilbron on September 28, 1999 and is headquartered in San Diego, CA.

Presidio Property Trust Inc - Ordinary Shares - Class A

SQFT is trending as a top gainer, attracting significant attention in pre-market trading, with community members pointing to its low float as a catalyst for potential massive spikes. Discussions highlight the stock's volatile movements and potential for both short-term gains and risks, with some traders taking profits while others anticipate further upside. The stock's behavior is also being compared to other high-flying tickers, with community members actively watching for breakout opportunities.

FG Nexus, Inc. engages in the provision of reinsurance, asset management and merchant banking services. The company was founded in October 2012 and is headquartered in Charlotte, NC.

FG Nexus Inc.

Fundamental Global Inc.

FGNX is trending due to the recent approval to issue one trillion shares, sparking community debate around potential dilution and the company's strategy to become a major Ethereum holder. Some traders are attracted to the stock's pre-market gains and potential for a rebound, while others express concern about the impact of the share issuance. The stock's connection to the crypto market, particularly Ethereum, is also a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DCTH share price over the last 12 months. 
 
It&#39;s our experience to date DCTH&#39;s Hepzato&#39;s kit is being rolled out into more hospitals (targeting 30 hospitals by year end) &amp; being prescribed to more patients every quarter since launch. Patient starts is another data point to follow (treats ocular melanoma like Kimmtrak from $IMCR). 
 
This is not investment advice but DCTH is down 31% from its peak 6 weeks ago. We don&#39;t suggest you buy DCTH because, for all we know, DCTH&#39;s share price could continue to fall. We only suggest you follow DCTH. Should they report Q2 2025 revenues that exceed forecast again, DCTH&#39;s share price could run as analytics suggest it is oversold. DCTH&#39;s share price jumped roughly 50% higher within 2 weeks after their Q1 2025 earnings conference call. Of course this may also never happen again. 
 
Like any commercial-stage oncology focused bios, ongoing trials could add another indication. $XBI $NBI

Paula

tom tom

koobaw

StockTwits Web

Delcath Systems Inc

Immunocore Holdings PLC - ADR

SPDR S&P Biotech ETF

NASDAQ Biotechnology

 share price over the last 12 months. 
 
It's our experience to date DCTH's Hepzato's kit is being rolled out into more hospitals (targeting 30 hospitals by year end) & being prescribed to more patients every quarter since launch. Patient starts is another data point to follow (treats ocular melanoma like Kimmtrak from 

). 
 
This is not investment advice but DCTH is down 31% from its peak 6 weeks ago. We don't suggest you buy DCTH because, for all we know, DCTH's share price could continue to fall. We only suggest you follow DCTH. Should they report Q2 2025 revenues that exceed forecast again, DCTH's share price could run as analytics suggest it is oversold. DCTH's share price jumped roughly 50% higher within 2 weeks after their Q1 2025 earnings conference call. Of course this may also never happen again. 
 
Like any commercial-stage oncology focused bios, ongoing trials could add another indication. 